{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:45:30Z","timestamp":1758041130194,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ajog.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T20:48:22Z","timestamp":1430858902000},"page":"398.e1-398.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals"],"prefix":"10.1016","volume":"213","author":[{"given":"Sabine Zoghbi","family":"Bousleiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline Murguia","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Todd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Rincon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Milluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felecia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francee","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Tolivaisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ranzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Costantine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Clock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Peaceman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dinsmoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Senka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Paychek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bailit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tillinghast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Timlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Iams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Varner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Morby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Thom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Spangler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Spong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Van Dorsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2004","series-title":"NIH Roadmap for Medical Research","key":"10.1016\/j.ajog.2015.05.005_bib1"},{"key":"10.1016\/j.ajog.2015.05.005_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.AOG.0000236434.74160.8b","article-title":"Evidence-based strategies for implementing guidelines in obstetrics: a systematic review","volume":"108","author":"Chaillet","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.05.005_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2307\/259164","article-title":"The challenge of innovation implementation","volume":"21","author":"Klein","year":"1996","journal-title":"Acad Manage Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A\u00a0controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2015.05.005_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","article-title":"The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials","volume":"97","author":"Crowley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation On Perinatal Outcomes","volume":"273","author":"Gilstrap","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.05.005_bib8","first-page":"1","article-title":"Antenatal corticosteroids revisited: repeat courses","volume":"17","year":"2000","journal-title":"NIH Consens State"},{"key":"10.1016\/j.ajog.2015.05.005_bib9","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib10","first-page":"CD003935","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease","author":"Crowther","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib11","first-page":"CD006764","article-title":"Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth","author":"Brownfoot","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17\u03b1-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.05.005_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the\u00a0incidence of spontaneous preterm birth in\u00a0women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib14","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.05.005_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2008.08.029","article-title":"Oral micronized progesterone for prevention of preterm birth","volume":"104","author":"Rai","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2015.05.005_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India","volume":"29","author":"Majhi","year":"2009","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-009-1351-2","article-title":"Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial","volume":"283","author":"Cetingoz","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2015.05.005_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1447-0756.2011.01524.x","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in prevention of preterm delivery","volume":"37","author":"Saghafi","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2015.05.005_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajog.2008.12.035","article-title":"Progesterone for preterm birth prevention: an evolving intervention","volume":"200","author":"Tita","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.AOG.0000275287.08520.4a","article-title":"Prediction and prevention of recurrent spontaneous preterm birth","volume":"110","author":"Spong","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ajog.2005.06.049","article-title":"Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials","volume":"194","author":"Mackenzie","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0b013e31817d0262","article-title":"Progesterone for the prevention of\u00a0preterm birth: a systematic review","volume":"112","author":"Dodd","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejogrb.2006.05.013","article-title":"Progesterone for the prevention of preterm birth: a critical evaluation of evidence","volume":"129","author":"Coomarasamy","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"112","key":"10.1016\/j.ajog.2015.05.005_bib26","first-page":"963","article-title":"Use of progesterone to reduce preterm birth. ACOG Committee Opinion no.\u00a0419, October 2008 (replaces no. 291, November 2003)","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Prediction and prevention of preterm birth. Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice bulletin no. 130","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/088307389200700113","article-title":"Maternal toxemia is associated with reduced incidence of\u00a0germinal matrix hemorrhage in premature babies","volume":"7","author":"Kuban","year":"1992","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ajog.2015.05.005_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","article-title":"Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?","volume":"95","author":"Nelson","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2015.05.005_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0301-2115(99)00256-0","article-title":"Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation","volume":"91","author":"Matsuda","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2015.05.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9378(98)70617-9","article-title":"Magnesium sulfate tocolysis and risk\u00a0of neonatal death","volume":"178","author":"Grether","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0887-8994(97)00073-8","article-title":"Pregnancy-induced hypertension and reduced intraventricular hemorrhage in preterm infants","volume":"17","author":"Perlman","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ajog.2015.05.005_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-994149","article-title":"Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants","volume":"14","author":"FineSmith","year":"1997","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2015.05.005_bib34","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/jama.1996.03540220029026","article-title":"Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years","volume":"276","author":"Schendel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.05.005_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9378(95)91270-3","article-title":"Reduction of cerebral palsy with maternal MgSO4 treatment in newborns weighing 500-1000 g","volume":"172","author":"Hauth","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib36","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1136\/fn.85.1.F13","article-title":"Effect of maternal tocolysis on the incidence of severe periventricular\/intraventricular haemorrhage in very low birthweight infants","volume":"85","author":"Weintraub","year":"2001","journal-title":"Arch Dis Childh Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2015.05.005_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mob.2000.106581","article-title":"Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia","volume":"183","author":"Grether","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/aje\/152.2.120","article-title":"Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams","volume":"152","author":"Boyle","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2015.05.005_bib39","first-page":"396","article-title":"Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage","volume":"93","author":"Canterino","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00006254-199910000-00010","article-title":"The effect of maternal magnesium sulfate treatment on neonatal morbidity in <1000-gram infants","volume":"54","author":"Kimberlin","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2015.05.005_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1542\/peds.102.2.315","article-title":"Perinatal correlates of cerebral palsy and other neurological impairment among very low birth weight children","volume":"102","author":"Wilson-Costello","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2015.05.005_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/oxfordjournals.aje.a009458","article-title":"Prenatal events and the risk of cerebral palsy in\u00a0very low birth weight infants","volume":"147","author":"O'Shea","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2015.05.005_bib43","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.99.5.e1","article-title":"Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants","volume":"99","author":"Paneth","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2015.05.005_bib44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A\u00a0randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.05.005_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.05.005_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.2006.01165.x","article-title":"The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months","volume":"114","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.05.005_bib47","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.05.005_bib48","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2002.123544","article-title":"Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants","volume":"186","author":"Mittendorf","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/AOG.0b013e3181ae98c2","article-title":"Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants a meta-analysis","volume":"114","author":"Costantine","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","article-title":"Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks\u2019 gestation: a systematic review and metaanalysis","volume":"200","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib51","first-page":"CD004661","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"Doyle","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1701-2163(16)34886-1","article-title":"Magnesium sulphate for fetal neuroprotection. Society of Obstetricians and Gynaecologists of Canada Clinical Practice Guideline No. 258","volume":"33","author":"Magee","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2015.05.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.01.014","article-title":"Magnesium for fetal neuroprotection","volume":"204","author":"Reeves","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","article-title":"Magnesium sulfate before anticipated preterm birth for neuroprotection. Committee Opinion no. 455","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib55","unstructured":"The Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: national clinical practice guidelines. Adelaide: Australian Research Centre for Health of Women and Babies, The University of Adelaide; 2010."},{"key":"10.1016\/j.ajog.2015.05.005_bib56","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/AOG.0b013e3181b48336","article-title":"Society for Maternal-Fetal Medicine. Magnesium sulfate for preterm labor and preterm birth","volume":"114","author":"Mercer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib57","first-page":"CD009302","article-title":"Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth","volume":"2","author":"Bain","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.05.005_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.0.CO;2-C","article-title":"Measuring climate for work group innovation: development and validation of the team climate inventory","volume":"19","author":"Anderson","year":"1998","journal-title":"J\u00a0Organ Behav"},{"key":"10.1016\/j.ajog.2015.05.005_bib59","first-page":"309","article-title":"The social psychology of innovation in groups","author":"West","year":"1990","journal-title":"Chichester (UK): Wiley;"},{"key":"10.1016\/j.ajog.2015.05.005_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1348\/096317999166644","article-title":"A\u00a0short version of the Team Climate Inventory: development and psychometric properties","volume":"72","author":"Kivimaki","year":"1999","journal-title":"J\u00a0Occup Organ Psychol"},{"key":"10.1016\/j.ajog.2015.05.005_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/qshc.2006.021543","article-title":"The Team Climate Inventory: application in hospital teams and methodological considerations","volume":"17","author":"Ouwens","year":"2008","journal-title":"Qual Safe Health Care"},{"key":"10.1016\/j.ajog.2015.05.005_bib62","doi-asserted-by":"crossref","first-page":"446.e1","DOI":"10.1016\/j.ajog.2013.07.019","article-title":"Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals","volume":"209","author":"Bailit","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib63","unstructured":"Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: CS M, ed. IJCAI '95 Proceedings of the 14th International Joint Conference on Artificial Intelligence. Vol 2, San Francisco, CA: Morgan Kaufmann Publishers Inc;\u00a01995."},{"key":"10.1016\/j.ajog.2015.05.005_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology (Cambridge, MA)"},{"issue":"Suppl","key":"10.1016\/j.ajog.2015.05.005_bib65","article-title":"Successes and failures in the implementation of evidence-based guidelines for clinical practice","volume":"39","author":"Grol","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.ajog.2015.05.005_bib66","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta8060","article-title":"Effectiveness and efficiency of guideline dissemination and implementation strategies","volume":"8","author":"Grimshaw","year":"2004","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.ajog.2015.05.005_bib67","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/AOG.0b013e31821c2d75","article-title":"Unjustified increase in cost of care resulting from US Food and Drug Administration approval of Makena (17\u03b1-hydroxyprogesterone caproate)","volume":"117","author":"Cohen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.05.005_bib68","first-page":"405","article-title":"Hydroxyprogesterone caproate injection (makena) one year later: to compound or not to compound that is the question","volume":"37","author":"Patel","year":"2012","journal-title":"P\u00a0T (Lawrenceville, NJ)"},{"key":"10.1016\/j.ajog.2015.05.005_bib69","unstructured":"US Department of Health and Human Services. FDA statement on Makena. 2011. Available at: PressAnnouncements\/2011\/ucm249025htm. Accessed Sept. 4, 2013."},{"key":"10.1016\/j.ajog.2015.05.005_bib70","unstructured":"US Department of Health and Human Services. FDA statement on Makena. 2011. Available at: PressAnnouncements\/2011\/ucm279098htm. Accessed Sept. 4, 2013."},{"key":"10.1016\/j.ajog.2015.05.005_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.0887-378X.2004.00325.x","article-title":"Diffusion of innovations in\u00a0service organizations: systematic review and\u00a0recommendations","volume":"82","author":"Greenhalgh","year":"2004","journal-title":"Milbank Q"},{"key":"10.1016\/j.ajog.2015.05.005_bib72","series-title":"Innovation and creativity at work: psychological and organizational strategies","article-title":"The social psychology of innovation in groups","author":"West","year":"1990"},{"key":"10.1016\/j.ajog.2015.05.005_bib73","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1037\/0021-9010.81.6.680","article-title":"Innovation in top management teams","volume":"81","author":"West","year":"1996","journal-title":"J\u00a0Appl Psychol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815004548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815004548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:03:43Z","timestamp":1757588623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815004548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0002937815004548"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.05.005","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}